AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06738901 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SKP-0141
Description: Human plasma-derived coagulation factor VIII concentrate
Study NCT06738745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-2189
Description: HRS-2189
Study NCT06738745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-5041
Description: HRS-5041
Study NCT05722496 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic pedaling exercise
Description: aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities
Study NCT05031858 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory physiotherapy
Description: Respiratory physiotherapy
Study NCT05031858 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory physiotherapy
Description: Respiratory physiotherapy
Study NCT05591729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Description: Each Pilates session will last for one hour. The subjects will be taught the 5 key elements of Pilates (lateral costal breathing, centering which is a neutral position of the lumbar spine with activation of the core muscles, ribcage placement, shoulder blade placement and neutral position of the cervical spine with slight upper cervical flexion at the craniocervical junction). A pilates exercise program will consist of 11 levels of treatment program.
Study NCT05591729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: postural correction exercise
Description: the patients will receive postural correction exercises, stretches, and exercises to the pectoralis major, elevator scapulae, upper trapezius, serratus anterior, rhomboids, and deep neck flexors. The stretches included sitting chair stretches, Brugger's, wall angels, and doorway stretches. The exercises included push-up-plus, head-neck-retraction, and Kibler squeeze
Study NCT05591729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: postural correction exercise
Description: the patients will receive postural correction exercises, stretches, and exercises to the pectoralis major, elevator scapulae, upper trapezius, serratus anterior, rhomboids, and deep neck flexors. The stretches included sitting chair stretches, Brugger's, wall angels, and doorway stretches. The exercises included push-up-plus, head-neck-retraction, and Kibler squeeze
Study NCT06734819 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Storytelling Video
Description: The Living Donation Storytelling Project (LDSP) is an online video library of living donation first-person narratives aiming to inspire more people to consider LDKT (https://livingdonationstories.org/).17 As of 2020, the library has 118 stories from living donors and kidney recipients sharing their experiences with the pursuit, challenges and outcomes of transplant.18,19 Four videos were selected from the LDSP and edited to standardized duration and thematic content. Videos were cut to three minutes in length and covered the topics of 1) challenges faced when seeking LDKT, 2) life after LDKT and 3) advice for other patients considering LDKT.
Study NCT06734819 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Patient Education
Description: Standard of care patient education materials include verbal didactic offered during the surgical consult and pamphlets produced by Vancouver Coastal Health.
Study NCT06734819 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Patient Education
Description: Standard of care patient education materials include verbal didactic offered during the surgical consult and pamphlets produced by Vancouver Coastal Health.
Study NCT06739473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movies
Description: Participants will watch eight short movie clips, and the changes different emotions evoked by the clips will be studied using H2\[15O\]O PET/CT.
Study NCT06739473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cold
Description: Participants will be studied with H2\[15O\]O PET/CT while one of their legs will be exposed to cold to study the effects of cold stimulus on whole-body blood flow.
Study NCT06739473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic euglycemic clamp
Description: Participants will be administered intravenous fast acting insulin (NovoRapid, Novo Nordisk, 1 mU/m2 body surface area/min) together with 20 % glucose to maintain normal glucose values (5.0 mmol/L) to study the effects of insulin on whole body blood flow with H2\[15O\]O PET/CT, and to assess tissue insulin-stimulated glucose uptake with \[18F\]FDG PET/CT.
Study NCT06739473 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: H2[15O]O PET/CT
Description: H2\[15O\]O PET/CT, with a dose of 25-700 MB/bolus repeated 2-8 times per scan.
Study NCT06739473 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: [18F]FDG PET/CT
Description: Whole-body \[18F\]FDG PET/CT scan to study tissue glucose uptake, dose 100 MBq
Study NCT06739473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CEUS or Contrast enhanced Ultrasound
Description: Contrast-enhanced ultrasound of left forearm muscles is performed during fasting and after 30-40 minutes of hyperinsulinemia
Study NCT06739759 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antagonist protocol for IVF
Description: antagonist protocol with triggering by Decapeptyl
Study NCT06739759 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Modified Agonist protocol for IVF with additive treatments as HCQ
Description: giving additive drugs to agonist protocolas HCQ
Study NCT04814186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafamidis
Description: 61 mg, once daily, oral administration, for 12 months.
Study NCT05171530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib plus taxane drugs
Description: * Drug: Paclitaxel Dose: 135mg/m2 Other Name: PTX~* Drug: Docetaxel Dose: 75mg/m2 Other Name: FA~* Drug: Lenvatinib Dose: 4mg, 8mg, 12mg,16mg Other Name: FA
Study NCT04084743 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality intervention
Description: Virtual reality intervention includes: Maze game software
Study NCT04084743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality intervention
Description: Virtual reality intervention includes: Maze game software
Study NCT04084743 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dual task intervention
Description: The intervention combined both motor and cognitive training which includes, walking 10 meter (1) Free walking (2) Walking carrying an emptying tray (3) Walking carrying a tray with 4 empty glasses (4) Digit calculations (Counting forward and backward, addition, subtraction, multiplication and division) during walking.
Study NCT04084743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dual task intervention
Description: The intervention combined both motor and cognitive training which includes, walking 10 meter (1) Free walking (2) Walking carrying an emptying tray (3) Walking carrying a tray with 4 empty glasses (4) Digit calculations (Counting forward and backward, addition, subtraction, multiplication and division) during walking.
Study NCT04084743 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: 1. Gait training in parallel bar~2. Balance activities which includes, a. Forward direction activity b. Backward direction activity c. Sideways direction activity
Study NCT04084743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: 1. Gait training in parallel bar~2. Balance activities which includes, a. Forward direction activity b. Backward direction activity c. Sideways direction activity
Study NCT06451744 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood samples collection
Description: 50 mL blood sample
Study NCT06451744 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Skin or mucous membrane brushing
Description: brushing on skin or mucous membrane lesions
Study NCT06451744 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Skin or mucous membrane biopsy
Description: 6 mm biopsy
Study NCT04157790 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CARE score
Description: CARE score calculation
Study NCT06263842 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: modified Elamrousy approach for socket shield technique
Description: the jumping gap will be filled with AWTG
Study NCT06263842 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional socket shield
Description: the jumping gap will be left ungrafted
Study NCT06263842 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: combined socket shild with xenograft
Description: the jumping gap will be filled with xenograft
Study NCT05014438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986166
Description: Specified dose on specified days
Study NCT05014438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Branebrutinib
Description: Specified dose on specified days
Study NCT05014438 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Specified dose on specified days
Study NCT06200480 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Telephone by nurse
Description: Patient-initiated follow-up at week 2 and 6
Study NCT06462573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: locally infilterating anaethesia like lidocaine
Description: which patients will undergo ESWL under locally infiltrated anaesthetic. Using ultrasound guidance, the quadratus lumborum muscle will be identified. Then a mixture of 0.5 % bupivacaine (10 ml) and 2 % lidocaine (10 ml) will be injected into the muscle as a single shot 20 minutes before the procedure.
Study NCT06462573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: general anaethesia
Description: which patients will undergo ESWL under systemic analgesia. The latter will be achieved using one gram of paracetamol IV infusion at the beginning of the procedure.~In case of unsatisfactory pain control in either group, systemic analgesia using IV Ketorolac injection will be used on demand or the required dose will be recorded at the end of the session.
Study NCT06491927 — intervention group
Intervention type: GENETIC
Intervention: No Intervention
Description: Observational study
Study NCT05356611 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Engage
Description: Engage is a 9-week, behavioral-based, psychotherapy treatment protocol for late-life depression.
Study NCT05852717 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: AutoSCT OR CAR T-cell Therapy
Description: Autologous stem cell transplant (AutoSCT) or CAR T-cell therapy will be performed after Cycle 3 of receiving epcoritamab and GDP
Study NCT05852717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDP
Description: Gemcitabine Cisplatin Dexamethasone
Study NCT06452758 — intervention group
Intervention type: OTHER
Intervention: 2000 meter ergometer test
Description: Rowers will perform 2000m ergometer test. A 2,000-meter trial is a standard test used to assess performance in rowers.
Study NCT06550869 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anterior Quadratus Lumborum Block at the lateral supra-arcuate ligament under laparoscopic direct vision
Description: The urologists find the inner arcuate ligament. The scalp needle is inserted from the midpoint of the lower edge of the inner or outer arcuate ligament towards the head to the dorsal side of the diaphragm. After withdrawing without blood, air, or cerebrospinal fluid, 2 ml of normal saline is first administered to observe the fluid spreading towards the head Then, 20 ml of 0.375% ropivacaine hydrochloride injection is administered.
Study NCT06550869 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local infiltration anesthesia
Description: The urologists give local infiltration anesthesia with 20 ml of 0.375% ropivacaine hydrochloride injection.
Study NCT05509023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADX-914
Description: Subcutaneous administration of ADX-914
Study NCT05509023 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous administration of Placebo
Study NCT05795959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Receive education on precision medicine
Description: Patients who consent to participating in the study and are randomized to the intervention group, will meet 1 on 1 with a trained lay VA volunteer. The trained lay VA volunteer will conduct phone calls with patients until the end of the 1 month enrollment period to deliver education regarding precision medicine.
Study NCT06372119 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole-stimulated cycle strategy
Description: Letrozole (Femara® 2.5 milligrams, Novartis, Switzerland or Lezra® 2.5 milligrams, Actavis, Rumani) 5 milligrams/day for 5 days, starting on the second to fourth day of the menstrual cycle.~Post-letrozole, ultrasound checks follicle growth. If ≥18mm, Ovitrelle® 250 mcg (Merck, Kenilworth, New Jersey, USA) induces ovulation.~Luteal phase support with vaginal micronized progesterone (Cyclogest® 400 milligrams, Actavis, UK or Utrogestan® 200 milligrams, Besins, Belgium) 800 milligrams/day starting two days post-hCG.~Embryo transfer, 5 days post-progesterone. Ultrasounds use Samsung HS-30, vaginal probe, and ≥7.5MHz frequency. Hormonal support until the 12th gestational week with vaginal micronized progesterone 800 milligrams/day.~Cycle cancellation criteria: no follicle development on day 21 from the day of starting letrozole, spontaneous ovulation, letrozole intolerance, fluid retention. Cycle cancellation will be noted as a study's outcome.
Study NCT06372119 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Artificial cycle strategy
Description: Oral estradiol valerate (Progynova® 2 milligrams, Bayer Pharma AG, Germany or Valiera® 2 milligrams, Laboratories Recalcine, Chile) 6 milligrams/day for 10 days, starting on the second to fourth day of the menstrual cycle.~Post-estradiol, ultrasound checks endometrial thickness. If ≥7mm, start vaginal micronized progesterone (Cyclogest® 400 milligrams, Actavis, UK or Utrogestan® 200 milligrams, Besins, Belgium) 800 milligrams/day. If \<7mm, increase the dose of oral estradiol valerate to 8 milligrams/day (5-6 days) and 12 milligrams/day (5-6 days).~Embryo transfer, 5 days post-progesterone. Ultrasounds use Samsung HS-30, vaginal probe, and ≥7.5MHz frequency. Hormonal support until the 12th gestational week with vaginal micronized progesterone 800 milligrams/day.~Cycle cancellation criteria: endometrial thickness \<7mm on day 21 of using estradiol, spontaneous ovulation, oral estradiol valerate intolerance, fluid retention. Cycle cancellation will be noted as a study's outcome.
Study NCT05010135 — intervention group
Intervention type: DEVICE
Intervention: Zebris Gait System assessment for gait weight distribution + EMG evaluation of Quadriceps, Hamstrings, Tib Anterior and Calves + Positional Sense assessment
Description: To measure the above parameters and to compare between the healthy subjects and the vertebral fracture subjects
Study NCT05448209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: walking exercise
Description: Intervention Group Afterwards, patients taking paclitaxel-paclitaxel-herceptin will be given a nurse-led Motivational Interview about CIPN, physical activity and regular physical activity-walking. Patients will be instructed that the goal is to beat the previous number of steps each time. If he/she has problems/shortness of breath, chest pain, palpitation complaints during walking, he/she will be told to take a break from walking and rest. The study will be conducted under the supervision of a Medical Oncology specialist throughout the study, as well as the controls of patients with ongoing symptoms. Participants will be given a pedometer for regular follow-up, its use will be explained, and it will be told to mark it on the walking tracking chart. It will be emphasized that rhythmic walking is important for the pedometer to count correctly. Motivational Interview sessions will be conducted face-to-face at the beginning, week 4 and week 8.
Study NCT04246229 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Transcutaneous bilirubinometry
Description: use of transcutaneous bilirubinometry a non-invasieve measurement of skin bilirubin levels
Study NCT04246229 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Serum bilirubin
Description: use of blood draws to measure serum bilirubin level
Study NCT05852717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epcoritamab
Description: Epcoritamab
Study NCT05360888 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tools for Life
Description: Tools for Life focuses on empowering youth to learn more about their culture and their identity.
Study NCT05897619 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Maya Perinatal Cognitive Behavioral Skills App
Description: The intervention includes the completion of a mobile skills app teaching evidence-based strategies tailored for perinatal mood and anxiety. Modules include psychoeducation, skill information, practice exercises, and homework.
Study NCT05274763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05274763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05274763 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spiritual Therapy
Description: Deliver or undergo Compassion Centered Spiritual Health (CCSH) session
Study NCT05826093 — intervention group
Intervention type: PROCEDURE
Intervention: Ultrasound-guided subcostal transversus abdominis plane block (US-TAP)
Description: US-TAP is a peripheral nerve block applied for postoperative pain relief. Subcostal refers to the approach which can also be lateral or posterior. In this trial the subcostal approach was used.
Study NCT05538338 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Platelet Rich Plasma Intrauterine infusion
Description: an intrauterine infusion of platelet rich plasma (PRP) will be administered to this group of participants
Study NCT05538338 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline Intrauterine infusion
Description: an intrauterine infusion of normal saline will be administered to this group of participants
Study NCT04790643 — intervention group
Intervention type: OTHER
Intervention: Exercise-based cardiac rehabilitation program (Stage 1)
Description: In Stage 1 the volunteers will perform 24 sessions of exercise-based cardiac rehabilitation. The rehabilitation session is composed of the following activities: I. Initial rest (where the vital signs are evaluated); II. Warming-up (composed of 15 minutes of stretching and global exercises); III. Aerobic exercise (composed of 30 minutes of treadmill or cycle ergometer exercise, the intensity established varies from 40 to 70% of the heart rate reserve for those diagnosed with cardiovascular diseases and from 60 to 80% of the heart rate reserve for those with only cardiac risk factors); IV. Cooldown (composed of 5 minutes of slow walking).
Study NCT04790643 — intervention group
Intervention type: OTHER
Intervention: Exercise-based cardiac rehabilitation program (Stage 2)
Description: In Stage 2, the volunteers will perform 24 sessions of exercise-based cardiac rehabilitation. The rehabilitation session is composed of the following activities: I. Initial rest; II. Warming-up; III. Aerobic exercise (these three activities are the same as stage 1); IV. Resistance training (composed of 15 minutes of individualized resistance exercises); V. Cooldown.
Study NCT05957146 — intervention group
Intervention type: DEVICE
Intervention: Routine hemodialysis
Description: * Dialyzers: Cordiax FX80 dialyzers; membrane material HelixonePlus (polysulfone); (Fresenius Medical Care Bad Homburg, Germany)~* Dialysis machines: Baxter Gambro AK 98 (Gambro Lundia AB, Lund, Sweden; part of Baxter Healthcare Corporation)~* Needles for vascular access: Nipro SafeTouch dialysis cath 1.6x25 mm (16G) or 1.9x25 mm (15G); or Nipro SafeTouch Tulip needles (15G; all Nipro Medical Europe Mechelen, Belgium)~* Ultrapure dialysis fluids (less than 0.1 colony forming units/ml, less than 0.03 endotoxin units/ml) will be mixed with AC-F 219/1 or 213/4 liquid acid concentrates and BiBag dry bicarbonate concentrate. Hence, the electrolyte composition of the dialysis fluid will be: Na 138-142 mmol/L; K 2.0-3.0 mmol/L; HCO3 26-35 mmol/L; Ca 1.25-1.50 mmol/L; Mg 0.5 mmol/L; Cl 108.5-109 mmol/L; glucose 5.6 mmol/L; acetate 3 mmol/L. Dialysate flow rate will be 500 mL/min.~* Anticoagulation: nadroparin.
Study NCT05360888 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tools for Life + MISN
Description: Tools for Life focuses on empowering youth to learn more about their culture and their identity. MISN focuses on helping youth get support from their community and social networks.
Study NCT05988931 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web Program + App
Description: Youth receive a brief interactive web program made available online to prevent alcohol misuse. The parent/caregiver app addresses monitoring and skill building for parents to communicate with the child about preventing underage drinking and drug use.
Study NCT05988931 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web Program + App + Text Messages
Description: Youth receive a brief interactive web program made available online to prevent alcohol misuse. This is followed by 8 weeks of supportive text messages. The parent/caregiver app addresses monitoring and skill building for parents to communicate with the child about preventing underage drinking and drug use.
Study NCT05094037 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Removable cam walker boot
Description: Standard of care device given to diabetic foot ulcer patients.